Atlas Trials

Clinical Characteristics and Treatment of Anosmia and Ageusia Due to SARS-CoV2 Variants

Clinical trial NCT06208540 · COMPLETED

Trial details

NCT number
NCT06208540
Sponsor
Sherifa Ahmed Hamed
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Post-covid-19 Persistent Smell and Taste Disorders
Start date
2021-08-30
Primary completion
2024-04-30
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.